Bare Metal Stent   
Trends in Acute Reperfusion Therapy for St-Segment Elevation Myocardial Infarction from 1999 to 2006: We Are Getting Better but We Have Got a Long Way to Go
Eur Heart J (2008) 29;609-17
K. A. Eagle, et al.
Increased Late Mortality after Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein Grafts: Results from the Randomized Delayed Rrisc Trial
J Am Coll Cardiol (2007) 50;261-7
P. Vermeersch, et al.
Offsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction after Paclitaxel-Eluting and Bare Metal Stent Implantation
Circulation (2007) 115;2842-7
G. W. Stone, et al.
A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
N Engl J Med (2007) 356;989-97
C. Spaulding, et al.
Randomized Comparative Trial of a Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Sirolimus-Eluting Stent for Coronary Revascularization
Catheter Cardiovasc Interv (2007) 69;790-8
P. Ortolani, et al.
Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (Sesami)
J Am Coll Cardiol (2007) 49;1924-30
M. Menichelli, et al.
Coronary Collateral Function Long after Drug-Eluting Stent Implantation
J Am Coll Cardiol (2007) 49;15-20
P. Meier, et al.
Comparison of Drug-Eluting Stents with Bare Metal Stents in Unselected Patients with Acute Myocardial Infarction
Catheter Cardiovasc Interv (2007) 70;1-8
L. I. Kupferwasser, et al.
Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
N Engl J Med (2007) 356;1030-9
A. Kastrati, et al.
Transition from Bare Metal to Drug Eluting Stenting in Contemporary Us Practice: Effect on Incidence and Predictors of Clinically Driven Target Lesion Revascularization
Catheter Cardiovasc Interv (2007) 70;175-83
M. Jonas, et al.
Influence of a Pressure Gradient Distal to Implanted Bare-Metal Stent on in-Stent Restenosis after Percutaneous Coronary Intervention
Circulation (2007) 116;2802-8
L. O. Jensen, et al.
Outcomes of Stent Thrombosis and Restenosis During Extended Follow-up of Patients Treated with Bare-Metal Coronary Stents
Circulation (2007) 116;2391-8
B. Doyle, et al.
Effectiveness of Drug-Eluting Stents in Patients with Bare-Metal in-Stent Restenosis: Meta-Analysis of Randomized Trials
J Am Coll Cardiol (2007) 49;616-23
A. Dibra, et al.
The Long-Term Value of Sirolimus- and Paclitaxel-Eluting Stents over Bare Metal Stents in Patients with Diabetes Mellitus
Eur Heart J (2007) 28;26-32
J. Daemen, et al.
Relocation of Minimal Luminal Diameter after Bare Metal and Drug-Eluting Stent Implantation: Incidence and Impact on Angiographic Late Loss
Catheter Cardiovasc Interv (2007) 69;181-8
M. A. Costa, et al.
Serial Angioscopic Evidence of Incomplete Neointimal Coverage after Sirolimus-Eluting Stent Implantation: Comparison with Bare-Metal Stents
Circulation (2007) 116;910-6
M. Awata, et al.
Unrestricted Use of Drug-Eluting Stents Compared with Bare-Metal Stents in Routine Clinical Practice: Findings from the National Heart, Lung, and Blood Institute Dynamic Registry
J Am Coll Cardiol (2007) 50;2029-36
J. D. Abbott, et al.